{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:14Z","timestamp":1787008994704,"version":"build-2736575974"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 immunity has declined with subsequent waves and accrual of viral mutations. In vitro studies raise concern for immune escape by BA.4\/BA.5, and a study in Qatar showed moderate protection, but these findings have yet to be reproduced.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included individuals tested for coronavirus disease 2019 by polymerase chain reaction during Delta or BA.1\/BA.2 and retested during BA.4\/BA.5. The preventable fraction (PF) was calculated as ratio of the infection to the hospitalization rate for initially positive patients divided by the ratio for initially negative patients, stratified by age and adjusted for age, sex, comorbid conditions, and vaccination using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20 987 patients met inclusion criteria. Prior Delta infection provided no protection against BA.4\/BA.5 infection (adjusted PF, 11.9% [95% confidence interval, .8%\u201321.8%]); P = .04) and minimal protection against hospitalization (10.7% [4.9%\u201321.7%]; P = .003). In adjusted models, prior BA.1\/BA.2 infection provided 45.9% (95% confidence interval, 36.2%\u201354.1%; P &amp;lt; .001) protection against BA.4\/BA.5 reinfection and 18.8% (10.3%\u201328.3%; (P &amp;lt; .001) protection against hospitalization. Up-to-date vaccination provided modest protection against reinfection with BA.4\/BA.5 and hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prior infection with BA.1\/BA.2 and up-to-date vaccination provided modest protection against infection with BA.4\/BA.5 and hospitalization, while prior Delta infection provided minimal protection against hospitalization and none against infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiad003","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T12:31:58Z","timestamp":1673008318000},"page":"800-805","source":"Crossref","is-referenced-by-count":5,"title":["Protection Conferred by Delta and BA.1\/BA.2 Infection Against BA.4\/BA.5 Infection and Hospitalization: A Retrospective Cohort Study"],"prefix":"10.1093","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-5320","authenticated-orcid":false,"given":"Nicole E","family":"Winchester","sequence":"first","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabin K","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Kim","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa G","family":"Tereshchenko","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Rothberg","sequence":"additional","affiliation":[{"name":"Center for Value-Based Care Research, Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"2023032810292123400_","volume-title":"COVID data tracker","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/cid\/ciab234","article-title":"Reinfection rates among patients who previously tested positive for coronavirus disease 2019: a retrospective cohort study","volume":"73","author":"Sheehan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study","volume":"397","author":"Hansen","year":"2021","journal-title":"Lancet"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1093\/cid\/ciab999","article-title":"Duration of severe acute respiratory syndrome coronavirus 2 natural immunity and protection against the Delta variant: a retrospective cohort study","volume":"75","author":"Kim","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2034545","article-title":"Antibody status and incidence of SARS-CoV-2 infection in health care workers","volume":"384","author":"Lumley","year":"2021","journal-title":"N Engl J Med"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1093\/cid\/ciac022","article-title":"Necessity of coronavirus disease 2019 (COVID-19) vaccination in persons who have already had COVID-19","volume":"75","author":"Shrestha","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023032810292123400_","article-title":"Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case-control study in France","volume":"13","author":"Grant","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cid\/ciab495","article-title":"Risk of reinfection after seroconversion to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a population-based propensity-score matched cohort study","volume":"74","author":"Leidi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jamainternmed.2021.2959","article-title":"Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy","volume":"181","author":"Vitale","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac604","article-title":"Protection against the Omicron variant offered by previous Severe Acute Respiratory Syndrome Coronavirus infection: a retrospective cohort study","volume":"76","author":"Rothberg","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron variant from previous SARS-CoV-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N Engl J Med"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated Omicron variant puts scientists on alert","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMc2209306","article-title":"Protective effect of previous SARS-CoV-2 infection against Omicron BA.4 and BA.5 subvariants","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"2023032810292123400_","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants United States, June 2021\u2013January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023032810292123400_","author":"Centers for Disease Control and Prevention"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad003\/49177731\/jiad003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/227\/6\/800\/49675866\/jiad003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/227\/6\/800\/49675866\/jiad003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T23:58:55Z","timestamp":1701647935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/227\/6\/800\/6982684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,1,10]]},"published-print":{"date-parts":[[2023,3,28]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.14.22282310","asserted-by":"object"}]},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,15]]},"published":{"date-parts":[[2023,1,10]]}}}